PSUSA/00000592/202503

EMEA-003402-PIP01-23

Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised

Q&A Clinic - New Variation Classification in eAF , Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 January 2026, 10:00 (CET) to 8 January 2026, 11:00 (CET)

Human medicines European public assessment report (EPAR): Verkazia, ciclosporin, Date of authorisation: 06/07/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation: 19/03/2015, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Date of authorisation: 19/11/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 11, Status: Authorised

Minutes of the COMP meeting 4-6 November 2025